U.S. Residential REITs Stock News

Wendy's (WEN) closed FY 2025 with Q4 revenue of US$543 million and basic EPS of US$0.14, supported by trailing twelve month revenue of about US$2.2 billion and EPS of US$0.85 that frame the latest quarter in a softer earnings backdrop. Over recent periods, revenue has moved from US$574 million and EPS of US$0.23 in Q4 2024 to US$543 million and EPS of US$0.14 in Q4 2025. Trailing twelve month EPS shifted from US$0.95 at Q4 2024 to US$0.85 at Q4 2025, setting a more cautious tone around...

Old Dominion Freight Line board member John R. "Jack" Congdon, Sr. has passed away, marking the loss of a long serving leader closely linked to the company’s evolution. Congdon was known for founding Old Dominion Truck Leasing and for his long tenure and influence on the culture and direction of NasdaqGS:ODFL. Management has publicly recognized his contributions, underscoring his importance to shareholders, employees, and the wider company community. For investors watching NasdaqGS:ODFL,...

If you are wondering whether Argan's share price still reflects fair value after a strong run, it helps to step back and look at what the current market price might be implying about the business. Argan's stock has been strong recently, with returns of 16.4% over the last 7 days, 6.9% over 30 days, 25.8% year to date and 178.1% over the past year. The 3 year and 5 year figures are very large at roughly 10x and 8x respectively. Recent moves are playing out against a steady flow of company and...

BofA Securities’ upgrade of SPX Technologies (SPXC) has put fresh attention on the stock. This comes alongside completed and planned HVAC acquisitions, as well as an emphasis on organic capacity additions, new products, and capital deployment. See our latest analysis for SPX Technologies. The recent upgrade and HVAC deals come on top of strong momentum, with a 1 day share price return of 3.5%, a 30 day share price return of 9.81%, and a 1 year total shareholder return of 60.41%. This points...

monday.com (NasdaqGS:MNDY) reported strong fourth quarter results, underscoring solid current business performance. The company issued a cautious revenue outlook for 2026, pointing to AI driven competitive pressures and softer demand from small businesses. Management indicated it will no longer emphasize long term revenue targets, signaling a shift in how it is framing future growth. monday.com, listed on NasdaqGS:MNDY, provides work management and collaboration tools used by teams across a...

NNN REIT (NYSE:NNN) reported a 36th consecutive year of dividend increases in 2025. The company recorded its highest ever annual acquisition volume, with more than $900m invested in new properties. NNN REIT highlighted a portfolio with high occupancy and long lease terms alongside this expansion. NNN REIT enters 2026 with a long dividend growth streak that sets it apart from many other U.S. listed companies. Its shares recently traded at $44.34, with the stock up 3.3% over the past week,...

What JBS stock’s recent move might be telling you JBS (NYSE:JBS) has attracted fresh attention after a recent share price move, with the stock up about 1.1% over the past week and roughly 9.1% over the past month. See our latest analysis for JBS. The recent 30 day share price return of 9.1% and 90 day return of 15.4% suggest building momentum for JBS, with the current share price at $16.0 anchoring those shorter term moves. If this has you thinking about where else momentum could be forming,...

In recent days, GATX’s business update highlighted slower-than-hoped adoption of its railcar solutions, rising cash burn, and a tight liquidity position that could require fresh equity financing. At the same time, the company has attracted strong institutional interest and AI-driven trading support, with market participants emphasizing operational momentum and long-term leasing fundamentals despite these financial pressures. We’ll now examine how this mix of robust institutional support and...

WEX (WEX) has just wrapped up FY 2025 with Q4 revenue of US$672.9 million and basic EPS of US$2.45, while full year trailing twelve month revenue came in at about US$2.7 billion and EPS at US$8.57. Over recent quarters the company has seen revenue move from US$636.5 million in Q4 2024 to US$672.9 million in Q4 2025, with basic EPS shifting from US$1.62 to US$2.45 over the same period, giving investors a clear view of how the top and bottom lines have tracked into this latest print. With a...

If you are wondering whether Hanover Insurance Group's share price still reflects its underlying worth, this article walks through the key numbers that matter before you commit fresh capital. The stock closed at US$171.80, with returns of 1.1% over 30 days, 7.8% over 1 year, 29.3% over 3 years and 70.4% over 5 years. This recent price history gives useful context for judging current value and risk. Recent coverage has focused on Hanover Insurance Group's position in the US insurance sector...

For investors wondering whether Encompass Health at around US$110 a share still offers value, or if the easy money has already been made, this article explains what the current price reflects. The stock has returned 4.5% over the last 7 days, 9.6% over 30 days, 3.5% year to date, 9.9% over 1 year, 79.3% over 3 years and 81.5% over 5 years. These figures naturally raise questions about what is now priced in. Recent attention on Encompass Health has focused on its position within US healthcare...

Pulmovant, a Roivant Sciences company, has completed patient enrollment in the Phase 2 PHocus trial of mosliciguat for pulmonary hypertension associated with interstitial lung disease. Enrollment finished ahead of schedule, marking a key clinical milestone for this potential first in class inhaled therapy. For investors watching Roivant Sciences (NasdaqGS:ROIV), this clinical update adds fresh context to a stock that has seen a very large 1 year return and a 20.6% gain year to date. Shares...

In early February 2026, Fortive Corporation reported fourth-quarter 2025 sales of US$1,122.5 million with continuing operations EPS edging higher year on year, even as full-year net income fell to US$579.2 million on modestly higher sales of US$4,159.1 million. Alongside these results, Fortive completed a multi-year buyback program totaling 43,483,303 shares for US$2,734.24 million, while management highlighted expanding recurring revenue and strong demand in its Fluke and international...

If you are wondering whether e.l.f. Beauty's share price still lines up with its underlying worth, this article will walk through what the current numbers are actually telling you. The stock most recently closed at US$81.50, with a 0.7% decline over 7 days, a 9.4% decline over 30 days, a 4.7% gain year to date, an 11.6% gain over 1 year and a very large gain over 5 years. Recent news flow around e.l.f. Beauty has focused on its position as a mass market cosmetics brand that aims to compete...

In February 2026, Gilead Sciences reported higher fourth-quarter and full-year 2025 revenue and earnings, raised its quarterly dividend to US$0.82 per share, completed a multi-year US$4.15 billion buyback program, and received FDA approval to remove key prescribing limitations for its Yescarta CAR T-cell therapy in certain lymphoma patients. Together, these moves highlight Gilead’s emphasis on returning cash to shareholders while trying to widen its oncology footprint alongside its...

Hasbro unveiled new products at the North American International Toy Fair, including its first Peppa Pig toy featuring a character with a hearing aid and an upcoming Magic: The Gathering "Universes Beyond" set. The company announced multi-year licensing agreements, highlighted by a new Harry Potter toy partnership with Warner Bros. Hasbro also introduced a digital advertising joint venture with Animaj focused on kids' entertainment content across digital platforms. For investors watching...

If you are wondering whether Ascendis Pharma's share price still reflects fair value after its recent run, this article will walk through what the numbers are saying right now. The stock last closed at US$216.32, with returns of 5.1% over the past 30 days and 50.1% over the past year, while the 7-day return of a 2.6% decline shows the ride has not been perfectly smooth. Recent moves sit against a backdrop of ongoing interest in Ascendis Pharma as a Nasdaq-listed pharmaceuticals and biotech...

In early February 2026, Corteva, Inc. reported fourth-quarter 2025 results showing quarterly sales of US$3,910 million and a net loss of US$552 million, alongside full-year 2025 sales of US$17.40 billion and net income of US$1.09 billion, and issued 2026 operating EPS guidance of US$3.45–US$3.70 per share. On the same day, UBS downgraded Corteva to a neutral stance as the company prepares to split its seed and crop protection businesses by early 2027, highlighting execution risks and higher...

If you are wondering whether Allegiant Travel's current share price really reflects its underlying worth, you are not alone. That is exactly what this article will unpack. The stock last closed at US$111.30, with returns of 23.7% over 30 days, 26.5% year to date, 33.7% over 1 year, 14.7% over 3 years, and a 52.6% decline over 5 years. Taken together, these figures paint a mixed picture of recent performance and shifting risk perceptions. Recent news around Allegiant Travel has focused on its...

North of South Capital reduced its stake in Vipshop Holdings in the fourth quarter. The move affects institutional ownership of Vipshop Holdings, ticker NYSE:VIPS. Vipshop continues to report profitability and run share buybacks despite the position cut. For you as a shareholder or watcher of NYSE:VIPS, this shift in ownership comes with a mixed backdrop. The stock closed at $17.54, with a 1 year return of 18.2% and a 3 year return of 35.3%. The 5 year return shows a 48.6% decline. Short...

LuxExperience B.V (LUXE) is back in focus after a cluster of analyst upgrades and fresh coverage, supported by robust reported sales, improving profitability in core brands, and ongoing progress on its multi year transformation plan. See our latest analysis for LuxExperience B.V. The 7 day share price return of 41.45% and 30 day share price return of 29.43% suggest strong short term momentum, even though the 1 year total shareholder return is a 5.32% loss and the 5 year total shareholder...

If you are wondering whether Wingstop shares still offer value after their recent swings, this article will walk through what the current price might be implying and how that stacks up against several valuation yardsticks. The stock closed at US$221.65, with returns of a 16% decline over 7 days, a 19.8% decline over 30 days, a 13.7% decline year to date, a 26.9% decline over 1 year, a 29.2% gain over 3 years and a 66.9% gain over 5 years, which may have shifted how investors see both its...

Dutch Bros (BROS) just wrapped up FY 2025 with fourth quarter revenue of US$443.6 million and basic EPS of US$0.17, capping a twelve month run that produced total revenue of about US$1.6 billion and EPS of roughly US$0.64. Over the past six quarters, the company has seen quarterly revenue move from US$338.2 million to US$443.6 million while basic EPS shifted from US$0.11 in Q3 2024 to a range of US$0.13 to US$0.20 across 2025. This sets up a story where higher net income and a trailing net...

Marathon Petroleum Corporation reported past fourth-quarter 2025 results with sales of US$32,574 million, revenue of US$33,422 million, and net income of US$1,535 million, alongside basic earnings per share from continuing operations of US$5.13. Despite slightly lower sales than a year earlier, the company’s net income and earnings per share rose sharply while it continued large-scale share repurchases, completing about US$45.70 billion of buybacks since 2017. With refining margins rising...